Skip to content

Pharminent

cropped-banner_frontpage_2026-07-11-2.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Regulatory
  • FDA, Moderna appear aligned on mRNA flu shot heading into adcomm
  • Regulatory

FDA, Moderna appear aligned on mRNA flu shot heading into adcomm

BioSpace

The Vaccines and Related Biological Products Advisory Committee will meet June 18 to discuss Moderna's seasonal flu vaccine mRNA-1010 after the FDA initially refused to accept the application in Febru

Infectious Disease

Read full story

pharminent June 16, 2026

BioSpace

The Vaccines and Related Biological Products Advisory Committee will meet June 18 to discuss Moderna’s seasonal flu vaccine mRNA-1010 after the FDA initially refused to accept the application in Febru

Infectious Disease

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: German said to be backtracking on pharma rebate changes
Next: Next Post

Related Stories

  • Regulatory

FDA approves MSD’s Keytruda combinations for MIBC

pharminent July 13, 2026
  • Regulatory

FDA freezes CRL trove as ‘radical transparency’ push hits speedbump

pharminent July 9, 2026
  • Regulatory

UK first in Europe to clear Boehringer’s IPF drug Jascayd

pharminent July 9, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.